{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:53:13Z","timestamp":1789501993896,"version":"build-2803163510"},"reference-count":84,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T00:00:00Z","timestamp":1566432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000870","name":"Pirbright Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2019.07.102","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T07:49:05Z","timestamp":1565336945000},"page":"5515-5524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory"],"prefix":"10.1016","volume":"37","author":[{"given":"D.J.","family":"Paton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2589-8091","authenticated-orcid":false,"given":"R.","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7117-9955","authenticated-orcid":false,"given":"A.V.","family":"Capozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ludi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2019.07.102_b0005","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/tbed.12373","article-title":"Review of the global distribution of foot-and-mouth disease virus from 2007 to 2014","volume":"64","author":"Brito","year":"2017","journal-title":"Transbound Emerg Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2019.07.102_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000149299","article-title":"Portraits of viruses: foot-and-mouth disease virus","volume":"18","author":"Brooksby","year":"1982","journal-title":"Intervirology"},{"issue":"9","key":"10.1016\/j.vaccine.2019.07.102_b0015","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41559-018-0636-x","article-title":"Waves of endemic foot-and-mouth disease in eastern Africa suggest feasibility of proactive vaccination approaches","volume":"2","author":"Casey-Bryars","year":"2018","journal-title":"Nat Ecol Evol"},{"issue":"10","key":"10.1016\/j.vaccine.2019.07.102_b0020","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.vaccine.2010.12.127","article-title":"Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen","volume":"29","author":"Nagendrakumar","year":"2011","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2019.07.102_b0025","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/j.vaccine.2014.02.092","article-title":"Emergence of antigenic variants of Foot-and-Mouth Disease Virus serotype O in Ecuador and preliminary evaluation of a field strain as a vaccine candidate","volume":"32","author":"Maradei","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.102_b0030","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1098\/rstb.2009.0100","article-title":"Options for control of foot-and-mouth disease: knowledge, capability and policy","volume":"364","author":"Paton","year":"2009","journal-title":"Phil Trans R Soc B"},{"key":"10.1016\/j.vaccine.2019.07.102_b0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.vetmic.2016.12.018","article-title":"Foot-and-mouth disease vaccines","volume":"206","author":"Diaz-San Segundo","year":"2017","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2019.07.102_b0040","series-title":"Applied virology","first-page":"73","article-title":"Factors influencing the performance of foot-and-mouth disease vaccines under field conditions","author":"Pay","year":"1984"},{"key":"10.1016\/j.vaccine.2019.07.102_b0045","series-title":"The Food and Agriculture Organization of the United Nations and the World Organisation for Animal Health","article-title":"Foot and mouth disease vaccines and post vaccination guidelines","author":"Ferrari","year":"2016"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.102_b0050","doi-asserted-by":"crossref","first-page":"117","DOI":"10.20506\/rst.26.1.1733","article-title":"Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination","volume":"26","author":"Lombard","year":"2007","journal-title":"Rev Sci Tech"},{"issue":"23","key":"10.1016\/j.vaccine.2019.07.102_b0055","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.vaccine.2018.04.090","article-title":"Alternate vaccine strain selection in the wake of emerging foot-and-mouth disease virus serotype A antigenic variants in India","volume":"31;36","author":"Mohapatra","year":"2018","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.102_b0060","doi-asserted-by":"crossref","first-page":"981","DOI":"10.20506\/rst.24.3.1632","article-title":"Selection of foot and mouth disease vaccine strains-a review","volume":"24","author":"Paton","year":"2005","journal-title":"Rev Sci Tech"},{"issue":"7","key":"10.1016\/j.vaccine.2019.07.102_b0065","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1080\/14760584.2018.1492378","article-title":"Foot and mouth disease vaccine strain selection: current approaches and future perspectives","volume":"17","author":"Mahapatra","year":"2018","journal-title":"Expert Rev Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.102_b0070","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1017\/S0022172400024451","article-title":"Variation among strains of type A foot-and-mouth disease virus in the Eastern Mediterranean region 1964\u20131972","volume":"75","author":"Arrowsmith","year":"1975","journal-title":"J Hyg (Lond)"},{"issue":"7","key":"10.1016\/j.vaccine.2019.07.102_b0075","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3201\/eid1507.081621","article-title":"Multiple origins of foot-and-mouth disease virus serotype Asia 1 outbreaks, 2003\u20132007","volume":"15","author":"Valarcher","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.07.102_b0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/tbed.12518","article-title":"Global foot-and-mouth disease research update and gap analysis: 6 \u2013 immunology","volume":"63","author":"Robinson","year":"2016","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2019.07.102_b0085","first-page":"501","article-title":"Observations on the duration of immunity in cattle after experimental infection with foot-and-mouth disease virus","volume":"54","author":"Cunliffe","year":"1964","journal-title":"Cornell Vet."},{"key":"10.1016\/j.vaccine.2019.07.102_b0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.virol.2018.02.012","article-title":"Systemic antibodies administered by passive immunization prevent generalization of the infection by foot-and-mouth disease virus in cattle after oronasal challenge","volume":"518","author":"Barrionuevo","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.07.102_b0095","first-page":"103","article-title":"Natural and vaccine induced immunity to FMD","volume":"288","author":"Doel","year":"2005","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2019.07.102_b0100","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0264-410X(98)00444-7","article-title":"Optimisation of the immune response to FMD vaccines","volume":"17","author":"Doel","year":"1999","journal-title":"Vaccine"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2019.07.102_b0105","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0264-410X(02)00691-6","article-title":"Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines","volume":"21","author":"Cox","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.102_b0110","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0034-5288(18)31084-1","article-title":"Endurance of immunity against foot-and-mouth disease in cattle after three consecutive annual vaccinations","volume":"49","author":"Terpstra","year":"1990","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2019.07.102_b0115","series-title":"Epitope dominance studies with serotype O foot-and-mouth disease","author":"Borley","year":"2012"},{"issue":"4","key":"10.1016\/j.vaccine.2019.07.102_b0120","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/CVI.00035-12","article-title":"Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus","volume":"19","author":"Szczepanek","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.07.102_b0125","unstructured":"OIE. Manual of diagnostic tests and vaccines for terrestrial animals. Chapter 3.1.8. Foot and mouth disease (infection with foot and mouth disease virus); 2018. p. 433\u201364. http:\/\/www.oie.int\/standard-setting\/terrestrial-manual\/access-online\/."},{"key":"10.1016\/j.vaccine.2019.07.102_b0130","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fvets.2016.00102","article-title":"Challenges of generating and maintaining protective vaccine-induced immune responses for foot-and-mouth disease virus in pigs","volume":"3","author":"Lyons","year":"2016","journal-title":"Front Vet Sci"},{"issue":"33","key":"10.1016\/j.vaccine.2019.07.102_b0135","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1016\/j.vaccine.2011.05.056","article-title":"Reducing animal experimentation in foot-and-mouth disease vaccine potency tests","volume":"29","author":"Reeve","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.102_b0140","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/0264-410X(92)90092-X","article-title":"Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge","volume":"10","author":"Pay","year":"1992","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2019.07.102_b0145","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1016\/j.vaccine.2008.09.021","article-title":"Foot-and-mouth disease vaccine potency testing: the influence of serotype, type of adjuvant, valency, fractionation method, and virus culture on the dose-response curve in cattle","volume":"26","author":"Jamal","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.07.102_b0150","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00493-18","article-title":"Contact challenge of cattle with foot-and-mouth disease virus validates the role of the nasopharyngeal epithelium as the site of primary and persistent infection","volume":"3","author":"Stenfeldt","year":"2018","journal-title":"mSphere"},{"issue":"4","key":"10.1016\/j.vaccine.2019.07.102_b0155","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/tbed.12478","article-title":"Herd immunity against foot-and-mouth disease under different vaccination practices in India","volume":"64","author":"Sharma","year":"2017","journal-title":"Transbound Emerg Dis"},{"issue":"48","key":"10.1016\/j.vaccine.2019.07.102_b0160","doi-asserted-by":"crossref","first-page":"6576","DOI":"10.1016\/j.vaccine.2014.06.056","article-title":"Influence of antibodies transferred by colostrum in the immune responses of calves to current foot-and-mouth disease vaccines","volume":"32","author":"Bucafusco","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.102_b0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/tbed.12130","article-title":"Heterogeneity in the antibody response to foot-and-mouth disease primo-vaccinated calves","volume":"62","author":"Di Giacomo","year":"2015","journal-title":"Transbound Emerg Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2019.07.102_b0170","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.vaccine.2005.08.071","article-title":"Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests","volume":"24","author":"Robiolo","year":"2006","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.vaccine.2019.07.102_b0175","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.vaccine.2014.01.071","article-title":"Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey","volume":"32","author":"Knight-Jones","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.102_b0180","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0167-5877(97)00014-7","article-title":"Assessment using ELISA of the herd immunity levels induced in cattle by foot-and-mouth disease oil vaccines","volume":"33","author":"Smitsaart","year":"1998","journal-title":"Preventive Veterinary Medicine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.07.102_b0185","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1128\/jvi.66.4.1835-1840.1992","article-title":"Protective immune response against foot-and-mouth disease","volume":"66","author":"McCullough","year":"1992","journal-title":"J Virol"},{"issue":"6\u20137","key":"10.1016\/j.vaccine.2019.07.102_b0190","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0264-410X(96)00284-8","article-title":"Total and isotype humoral responses in cattle vaccinated with foot and mouth disease virus (FMDV) immunogen produced either in bovine tongue tissue or in BHK-21 cell suspension cultures","volume":"15","author":"Capozzo","year":"1997","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2019.07.102_b0195","doi-asserted-by":"crossref","first-page":"e44365","DOI":"10.1371\/journal.pone.0044365","article-title":"Interferon-\u03b3 induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection","volume":"7","author":"Oh","year":"2012","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.vaccine.2019.07.102_b0200","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.vaccine.2008.01.038","article-title":"High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus","volume":"26","author":"Brehm","year":"2008","journal-title":"Vaccine"},{"issue":"31\u201332","key":"10.1016\/j.vaccine.2019.07.102_b0205","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1016\/j.vaccine.2004.06.040","article-title":"Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease","volume":"22","author":"Mattion","year":"2004","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2019.07.102_b0210","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.1016\/j.vaccine.2016.06.073","article-title":"Protection induced by a commercial bivalent vaccine against Foot-and-Mouth Disease 2010 field virus from Ecuador","volume":"34","author":"Duque","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2019.07.102_b0215","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.vaccine.2018.11.080","article-title":"Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O\/Jincheon\/SKR\/2014 in pig","volume":"37","author":"Kim","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.102_b0220","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1090-0233(03)00087-X","article-title":"Developments in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease","volume":"167","author":"Clavijo","year":"2004","journal-title":"Vet J"},{"issue":"23","key":"10.1016\/j.vaccine.2019.07.102_b0225","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1016\/S0264-410X(03)00219-6","article-title":"Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach","volume":"21","author":"Barnett","year":"2003","journal-title":"Vaccine"},{"issue":"51","key":"10.1016\/j.vaccine.2019.07.102_b0230","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1016\/j.vaccine.2008.09.033","article-title":"Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina","volume":"26","author":"Maradei","year":"2008","journal-title":"Vaccine"},{"issue":"38","key":"10.1016\/j.vaccine.2019.07.102_b0235","doi-asserted-by":"crossref","first-page":"6235","DOI":"10.1016\/j.vaccine.2010.07.012","article-title":"Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests","volume":"28","author":"Robiolo","year":"2010","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2019.07.102_b0240","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1016\/j.vaccine.2012.07.015","article-title":"Characteristics of serology-based vaccine potency models for foot-and-mouth disease virus","volume":"30","author":"Willems","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2019.07.102_b0245","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12917-018-1686-7","article-title":"Evaluation and optimization of a conventional SPCE for FMD post-vaccination monitoring","volume":"14","author":"Kang","year":"2018","journal-title":"BMC Vet Res"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.102_b0250","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-1157(84)80013-X","article-title":"Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction","volume":"12","author":"Rweyemamu","year":"1984","journal-title":"J Biol Standard"},{"issue":"5","key":"10.1016\/j.vaccine.2019.07.102_b0255","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/CVI.00034-14","article-title":"Comparison of test methodologies for foot-and-mouth disease virus serotype A vaccine matching","volume":"21","author":"Tekleghiorghis","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.07.102_b0260","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.vaccine.2008.11.026","article-title":"Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology","volume":"27","author":"Mattion","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2019.07.102_b0265","doi-asserted-by":"crossref","first-page":"e0159360","DOI":"10.1371\/journal.pone.0159360","article-title":"Tracking the antigenic evolution of Foot-and-Mouth disease virus","volume":"11","author":"Reeve","year":"2016","journal-title":"PLoS One"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2019.07.102_b0270","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1016\/j.vaccine.2008.04.034","article-title":"Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the \u201cProtection against Podal Generalisation\u201d test","volume":"26","author":"Goris","year":"2008","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2019.07.102_b0275","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1016\/j.vaccine.2012.09.011","article-title":"Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against Foot-and-Mouth Disease Virus in cattle","volume":"30","author":"Lavoria","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.07.102_b0280","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.vaccine.2013.12.007","article-title":"Accuracy of traditional and novel serology tests for predicting cross-protection in foot-and-mouth disease vaccinated cattle","volume":"32","author":"Brito","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.102_b0285","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/emboj\/18.3.543","article-title":"The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex","volume":"18","author":"Fry","year":"1999","journal-title":"EMBO J"},{"issue":"6","key":"10.1016\/j.vaccine.2019.07.102_b0290","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.3201\/eid2406.170715","article-title":"Foot-and-Mouth disease in the Middle East caused by an A\/ASIA\/G-VII virus lineage, 2015\u20132016","volume":"24","author":"Bachanek-Bankowska","year":"2018","journal-title":"Emerg Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2019.07.102_b0295","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.vaccine.2018.02.016","article-title":"Efficacy of a high-potency multivalent foot-and-mouth disease virus vaccine in cattle against heterologous challenge with a field virus from the emerging A\/ASIA\/G-VII lineage","volume":"36","author":"Waters","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.102_b0300","first-page":"369","article-title":"Some statistical and experimental design problems in the assessment of FMD vaccine potency","volume":"35","author":"Pay","year":"1977","journal-title":"Dev Biol Stand"},{"issue":"4","key":"10.1016\/j.vaccine.2019.07.102_b0305","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/BF01242879","article-title":"A simple method for the quantification of 140S particles of foot-and-mouth disease virus (FMDV)","volume":"45","author":"Barteling","year":"1974","journal-title":"Arch Gesamte Virusforsch"},{"issue":"41","key":"10.1016\/j.vaccine.2019.07.102_b0310","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1016\/j.vaccine.2011.05.078","article-title":"Foot and mouth disease (FMD) virus: quantification of whole virus particles during the vaccine manufacturing process by size exclusion chromatography","volume":"29","author":"Spitteler","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.07.102_b0315","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/1045-1056(90)90036-Y","article-title":"Quantification of intact 146S foot-and-mouth disease antigen for vaccine production by a double antibody sandwich ELISA using monoclonal antibodies","volume":"18","author":"Van Maanen","year":"1990","journal-title":"Biologicals"},{"issue":"7","key":"10.1016\/j.vaccine.2019.07.102_b0320","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1099\/jgv.0.000462","article-title":"Application of the thermofluor PaSTRy technique for improving foot-and-mouth disease virus vaccine formulation","volume":"97","author":"Kotecha","year":"2016","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.102_b0325","doi-asserted-by":"crossref","first-page":"e0149569","DOI":"10.1371\/journal.pone.0149569","article-title":"Quantitative detection of the Foot-And-Mouth disease virus serotype O 146S antigen for vaccine production using a double-antibody sandwich ELISA and nonlinear standard curves","volume":"11","author":"Feng","year":"2016","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2019.07.102_b0330","doi-asserted-by":"crossref","first-page":"e1001027","DOI":"10.1371\/journal.pcbi.1001027","article-title":"Sequence-based prediction for vaccine strain selection and identification of antigenic variability in foot-and-mouth disease virus","volume":"6","author":"Reeve","year":"2010","journal-title":"PLoS Comput Biol"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2019.07.102_b0335","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1099\/vir.0.037952-0","article-title":"Foot-and-mouth disease virus epitope dominance in the antibody response of vaccinated animals","volume":"93","author":"Mahapatra","year":"2012","journal-title":"J Gen Virol"},{"issue":"Pt 10","key":"10.1016\/j.vaccine.2019.07.102_b0340","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1099\/vir.0.032839-0","article-title":"Predicting antigenic sites on the foot-and-mouth disease virus capsid of the South African Territories types using virus neutralization data","volume":"92","author":"Maree","year":"2011","journal-title":"J Gen Virol."},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2019.07.102_b0345","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1099\/vir.0.000051","article-title":"Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis","volume":"96","author":"Bari","year":"2015","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.102_b0350","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00180-017-0730-6","article-title":"A sparse hierarchical Bayesian model for detecting relevant antigenic sites in virus evolution","volume":"32","author":"Davies","year":"2017","journal-title":"Comput Stat"},{"issue":"36","key":"10.1016\/j.vaccine.2019.07.102_b0355","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/j.vaccine.2015.06.090","article-title":"Strengthening the influenza vaccine virus selection and development process: report of the 3rd WHO informal consultation for improving influenza vaccine virus selection held at WHO headquarters, Geneva, Switzerland, 1\u20133 April 2014","volume":"33","author":"Ampofo","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.102_b0360","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4065\/mcp.2009.0615","article-title":"Influenza vaccines: from surveillance through production to protection","volume":"85","author":"Tosh","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.102_b0365","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/21645515.2017.1413518","article-title":"The establishment of surrogates and correlates of protection: useful tools for the licensure of effective influenza vaccines?","volume":"14","author":"Ward","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"10.1016\/j.vaccine.2019.07.102_b0370","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.vaccine.2017.01.018","article-title":"Improving the selection and development of influenza vaccine viruses \u2013 report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18\u201320 November 2015","volume":"35","author":"Hampson","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.07.102_b0375","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1126\/science.1097211","article-title":"Mapping the antigenic and genetic evolution of influenza virus","volume":"305","author":"Smith","year":"2004","journal-title":"Science"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2019.07.102_b0380","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1099\/vir.0.057521-0","article-title":"Antigenic variation of foot-and-mouth disease virus serotype A","volume":"95","author":"Ludi","year":"2014","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.07.102_b0385","doi-asserted-by":"crossref","first-page":"e1005526","DOI":"10.1371\/journal.ppat.1005526","article-title":"Identification of low- and high-impact hemagglutinin amino acid substitutions that drive antigenic drift of influenza A(H1N1) viruses","volume":"12","author":"Harvey","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.07.102_b0390","article-title":"Improving the identification of antigenic sites in the H1N1 Influenza virus through accounting for the experimental structure in a sparse hierarchical Bayesian model","author":"Davies","year":"2019","journal-title":"J Roy Stat Soc: Ser C (Appl Stat)"},{"key":"10.1016\/j.vaccine.2019.07.102_b0395","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.3389\/fmicb.2018.02500","article-title":"Predicting influenza antigenicity by matrix completion with antigen and antiserum similarity","volume":"9","author":"Wang","year":"2018","journal-title":"Front Microbiol"},{"issue":"7490","key":"10.1016\/j.vaccine.2019.07.102_b0400","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature13087","article-title":"A predictive fitness model for influenza","volume":"507","author":"\u0141uksza","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2019.07.102_b0405","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1371\/journal.pntd.0000595","article-title":"Rabies-specific antibodies: measuring surrogates of protection against a fatal disease","volume":"4","author":"Moore","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.07.102_b0410","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biologicals.2017.02.002","article-title":"G-protein based ELISA as a potency test for rabies vaccines","volume":"46","author":"Chabaud-Riou","year":"2017","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2019.07.102_b0415","first-page":"425","article-title":"Rabies vaccines","volume":"82","author":"WHO","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"issue":"4","key":"10.1016\/j.vaccine.2019.07.102_b0420","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.biologicals.2014.04.001","article-title":"Replacing the NIH test for rabies vaccine potency testing: a synopsis of drivers and barriers","volume":"42","author":"Schiffelers","year":"2014","journal-title":"Biologicals"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19310230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:34:16Z","timestamp":1759401256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19310230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":84,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X19310230"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.102","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}